UnitedHealth Group Inc Faces Expanded Investigation

UnitedHealth Group Inc, the largest US health insurer, is facing renewed scrutiny from the Department of Justice (DOJ). The DOJ has expanded its criminal investigation into the company’s business practices, which now includes areas beyond Medicare Advantage billing.

The investigation has been broadened to examine the company’s prescription management services and doctor reimbursements. This development has led to a decline in the company’s stock price, which has struggled to remain above $300.

UnitedHealth Group has issued a statement expressing confidence in its business practices. However, the ongoing investigation has raised concerns among investors and analysts.

Key Developments:

• The DOJ’s investigation has been expanded to include prescription management services and doctor reimbursements
• UnitedHealth Group’s stock price has declined, struggling to stay above $300
• The company has expressed confidence in its business practices